Actionable news
All posts from Actionable news
Actionable news in ACHN: Achillion Pharmaceuticals, Inc.,

Achillion Pharmaceuticals Shares Shoot Up On Positive Trial Results

Achillion Pharmaceuticals, Inc. (ACHN), a global a biopharmaceutical company yesterday reported their second quarter 2017 financial results.

Achillion reported a second quarter loss of $22.5 million Achillion reported adjusted second quarter earnings of a loss of $0.16 per share which exactly what analysts were expecting.

Achillion Pharmaceuticals, Inc. CEO’s Comments

“Our focus in early clinical development with ACH-4471 has been on achieving proof-of-concept via factor D inhibition, and we are pleased to report that we believe we have achieved this goal. The emerging interim results from our phase 2 PNH trial have demonstrated a dose response to treatment with what we believe to be...